Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Highlights on Most Cited Publications 2019-2020

Author(s): Jia Zhou*

Volume 22, Issue 21, 2022

Published on: 26 September, 2022

Page: [1729 - 1730] Pages: 2

DOI: 10.2174/1568026622666220913104757

Next »
[1]
Ivasiv, V.; Albertini, C.; Gonçalves, A.E.; Rossi, M.; Bolognesi, M.L. Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases. Curr. Top. Med. Chem., 2019, 19(19), 1694-1711.
[http://dx.doi.org/10.2174/1568026619666190619115735] [PMID: 31237210]
[2]
da Silva Rocha, S.F.L.; Olanda, C.G.; Fokoue, H.H.; Sant’Anna, C.M.R. Virtual screening techniques in drug discovery: Review and recent applications. Curr. Top. Med. Chem., 2019, 19(19), 1751-1767.
[http://dx.doi.org/10.2174/1568026619666190816101948] [PMID: 31418662]
[3]
Nguyen, T.; Thomas, B.F.; Zhang, Y. Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: current approaches for therapeutics development. Curr. Top. Med. Chem., 2019, 19(16), 1418-1435.
[http://dx.doi.org/10.2174/1568026619666190708164841] [PMID: 31284863]
[4]
Saxena, M.; Dubey, R. Target enzyme in Alzheimer’s disease: Acetylcholinesterase inhibitors. Curr. Top. Med. Chem., 2019, 19(4), 264-275.
[http://dx.doi.org/10.2174/1568026619666190128125912] [PMID: 30706815]
[5]
Sharma, P.; Sharma, A.; Fayaz, F.; Wakode, S.; Pottoo, F.H. Biological signatures of Alzheimer’s disease. Curr. Top. Med. Chem., 2020, 20(9), 770-781.
[http://dx.doi.org/10.2174/1568026620666200228095553] [PMID: 32108008]
[6]
Hu, Y.S.; Han, X.; Liu, X.H. STAT3: A potential drug target for tumor and inflammation. Curr. Top. Med. Chem., 2019, 19(15), 1305-1317.
[http://dx.doi.org/10.2174/1568026619666190620145052] [PMID: 31218960]
[7]
Sabbah, D.A.; Hajjo, R.; Sweidan, K. Review on Epidermal Growth Factor Receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors. Curr. Top. Med. Chem., 2020, 20(10), 815-834.
[http://dx.doi.org/10.2174/1568026620666200303123102] [PMID: 32124699]
[8]
Li, Y.; Wang, F.; Chen, X.; Wang, J.; Zhao, Y.; Li, Y.; He, B. Zinc-dependent Deacetylase (HDAC) inhibitors with different zinc binding groups. Curr. Top. Med. Chem., 2019, 19(3), 223-241.
[http://dx.doi.org/10.2174/1568026619666190122144949] [PMID: 30674261]
[9]
Duan, Y.; Liu, W.; Tian, L.; Mao, Y.; Song, C. Targeting tubulin-colchicine site for cancer therapy: inhibitors, antibody- drug conjugates and degradation agents. Curr. Top. Med. Chem., 2019, 19(15), 1289-1304.
[http://dx.doi.org/10.2174/1568026619666190618130008] [PMID: 31210108]
[10]
Chen, S.; Song, Z.; Zhang, A. Small-molecule immuno-oncology therapy: Advances, challenges and new directions. Curr. Top. Med. Chem., 2019, 19(3), 180-185.
[http://dx.doi.org/10.2174/1568026619666190308131805] [PMID: 30854972]
[11]
Kumar, S. Poonam; Rathi, B. Coronavirus disease COVID-19: A new threat to public health. Curr. Top. Med. Chem., 2020, 20(8), 599-600.
[http://dx.doi.org/10.2174/1568026620999200305144319] [PMID: 32133964]
[12]
Maeda, K.; Das, D.; Kobayakawa, T.; Tamamura, H.; Takeuchi, H. Discovery and development of anti-hiv therapeutic agents: Progress towards improved HIV medication. Curr. Top. Med. Chem., 2019, 19(18), 1621-1649.
[http://dx.doi.org/10.2174/1568026619666190712204603] [PMID: 31424371]
[13]
Saxena, A.K.; Singh, A. Mycobacterial tuberculosis enzyme targets and their inhibitors. Curr. Top. Med. Chem., 2019, 19(5), 337-355.
[http://dx.doi.org/10.2174/1568026619666190219105722] [PMID: 30806318]
[14]
Liu, X.; Cao, J.; Huang, G.; Zhao, Q.; Shen, J. Biological activities of artemisinin derivatives beyond malaria. Curr. Top. Med. Chem., 2019, 19(3), 205-222.
[http://dx.doi.org/10.2174/1568026619666190122144217] [PMID: 30674260]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy